Education / Graduate Medical Education / Prospective Fellows / Infectious Diseases Fellowship / Research / Peer Reviewed Publications

Recent Peer Reviewed Publications

1. Panozzo CA
2. Walsh EE
3. Yang Z
4. Wilson E
5. Goswami J
6. Stoszek SK
7. Loback A
8. Ng T
9. Francis BM
10. Simorellis AK
11. Huang W
12. Li L
13. Vislay-Wade R
14. Zheng Z
15. Anderson EJ
16. August A
17. Chen G
18. Falsey AR
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults.; Infectious diseases and therapy. 2024 Nov 16.
1. Frutos AM
2. Ahmad HM
3. Ujamaa D
4. O'Halloran AC
5. Englund JA
6. Klein EJ
7. Zerr DM
8. Crossland M
9. Staten H
10. Boom JA
11. Sahni LC
12. Halasa NB
13. Stewart LS
14. Hamdan O
15. Stopczynski T
16. Schaffner W
17. Talbot HK
18. Michaels MG
19. Williams JV
20. Sutton M
21. Hendrick MA
22. Staat MA
23. Schlaudecker EP
24. Tesini BL
25. Felsen CB
26. Weinberg GA
27. Szilagyi PG
28. Anderson BJ
29. Rowlands JV
30. Khalifa M
31. Martinez M
32. Selvarangan R
33. Schuster JE
34. Lynfield R
35. McMahon M
36. Kim S
37. Nunez VT
38. Ryan PA
39. Monroe ML
40. Wang YF
41. Openo KP
42. Meek J
43. Yousey-Hindes K
44. Alden NB
45. Armistead I
46. Rao S
47. Chai SJ
48. Kirley PD
49. Toepfer AP
50. Dawood FS
51. Moline HL
52. Uyeki TM
53. Ellington S
54. Garg S
55. Bozio CH
56. Olson SM
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024.; MMWR. Morbidity and mortality weekly report; Vol 73(45), pp. 1022-1029. 2024 Nov 14.
1. Paras ML
2. Chirch LM
3. Aziz M
4. Balba GP
5. Benson C
6. Butt S
7. James SH
8. McCarty TP
9. Razonable R
10. Reece R
11. Shnekendorf R
12. Swartz TH
13. Viehman JA
14. Luther VP
Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive Messaging.; Open forum infectious diseases; Vol 11(12), pp. ofae669. 2024 Nov 12.
1. O'Halloran AC
2. Millman AJ
3. Holstein R
4. Olsen SJ
5. Cummings C
6. Chai SJ
7. Kirley PD
8. Alden NB
9. Yousey-Hindes K
10. Meek J
11. Openo KP
12. Fawcett E
13. Ryan PA
14. Leegwater L
15. Henderson J
16. McMahon M
17. Lynfield R
18. Angeles KM
19. Bleecker M
20. McGuire S
21. Spina NL
22. Tesini BL
23. Gaitan MA
24. Lung K
25. Shiltz E
26. Thomas A
27. Talbott HK
28. Schaffner W
29. Hill M
30. Reed C
31. Garg S
The burden of all-cause mortality following influenza-associated hospitalizations, FluSurv-NET, 2010-2019.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Nov 04.
1. Havers FP
2. Whitaker M
3. Melgar M
4. Pham H
5. Chai SJ
6. Austin E
7. Meek J
8. Openo KP
9. Ryan PA
10. Brown C
11. Como-Sabetti K
12. Sosin DM
13. Barney G
14. Tesini BL
15. Sutton M
16. Talbot HK
17. Chatelain R
18. Daily Kirley P
19. Armistead I
20. Yousey-Hindes K
21. Monroe ML
22. Tellez Nunez V
23. Lynfield R
24. Esquibel CL
25. Engesser K
26. Popham K
27. Novak A
28. Schaffner W
29. Markus TM
30. Swain A
31. Patton ME
32. Kim L
Burden of Respiratory Syncytial Virus-Associated Hospitalizations in US Adults, October 2016 to September 2023.; JAMA network open; Vol 7(11), pp. e2444756. 2024 Nov 04.
1. Taylor CA
2. Whitaker M
3. Patton ME
4. Melgar M
5. Kirley PD
6. Kawasaki B
7. Yousey-Hindes K
8. Openo KP
9. Ryan PA
10. Kim S
11. Como-Sabetti K
12. Solhtalab D
13. Barney G
14. Tesini BL
15. Moran NE
16. Sutton M
17. Talbot HK
18. Olsen K
19. Havers FP
Trends in COVID-19-Attributable Hospitalizations Among Adults With Laboratory-Confirmed SARS-CoV-2-COVID-NET, June 2020 to September 2023.; Influenza and other respiratory viruses; Vol 18(11), pp. e70021. 2024 Nov.
1. Saiman L
2. Walsh EE
3. Branche AR
4. Barrett A
5. Alba L
6. Gollerkeri S
7. Schillinger JA
8. Phillips M
9. Finelli L
Impact of Age and Comorbid Conditions on Incidence Rates of COVID-19-Associated Hospitalizations, 2020-2021.; Influenza and other respiratory viruses; Vol 18(11), pp. e70016. 2024 Nov.
1. Naquin A
2. O'Halloran A
3. Ujamaa D
4. Sundaresan D
5. Masalovich S
6. Cummings CN
7. Noah K
8. Jain S
9. Kirley PD
10. Alden NB
11. Austin E
12. Meek J
13. Yousey-Hindes K
14. Openo K
15. Witt L
16. Monroe ML
17. Henderson J
18. Nunez VT
19. Lynfield R
20. McMahon M
21. Shaw YP
22. McCahon C
23. Spina N
24. Engesser K
25. Tesini BL
26. Gaitan MA
27. Shiltz E
28. Lung K
29. Sutton M
30. Hendrick MA
31. Schaffner W
32. Talbot HK
33. George A
34. Zahid H
35. Reed C
36. Garg S
37. Bozio CH
Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults - Influenza Hospitalization Surveillance Network, United States, 2010-2023.; Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002); Vol 73(6), pp. 1-18. 2024 Oct 31.
1. Branche AR
Real-world effectiveness studies of the benefit of RSV vaccines.; Lancet (London, England); Vol 404(10462), pp. 1498-1500. 2024 Oct 19.
1. Dobrzynski D
2. Branche AR
3. Falsey AR
Combination seasonal vaccines for influenza, RSV, SARS-CoV-2, and other pathogens.; The Journal of infectious diseases. 2024 Oct 15.
1. Devine O
2. Pham H
3. Gunnels B
4. Reese HE
5. Steele M
6. Couture A
7. Iuliano D
8. Sachdev D
9. Alden NB
10. Meek J
11. Witt L
12. Ryan PA
13. Reeg L
14. Lynfield R
15. Ropp SL
16. Barney G
17. Tesini BL
18. Shiltz E
19. Sutton M
20. Talbot HK
21. Reyes I
22. Havers FP
Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach.; Influenza and other respiratory viruses; Vol 18(10), pp. e70026. 2024 Oct.
1. Fong Y
2. Dang L
3. Zhang B
4. Fintzi J
5. Chen S
6. Wang J
7. Rouphael NG
8. Branche AR
9. Diemert DJ
10. Falsey AR
11. Losada C
12. Baden LR
13. Frey SE
14. Whitaker JA
15. Little SJ
16. Kamidani S
17. Walter EB
18. Novak RM
19. Rupp R
20. Jackson LA
21. Yu C
22. Magaret CA
23. Molitor C
24. Borate B
25. Babu TM
26. Kottkamp AC
27. Luetkemeyer AF
28. Immergluck LC
29. Presti RM
30. Bäcker M
31. Winokur PL
32. Mahgoub SM
33. Goepfert PA
34. Fusco DN
35. Atmar RL
36. Posavad CM
37. Mu J
38. Makowski M
39. Makhene MK
40. Nayak SU
41. Roberts PC
42. Follmann D
43. Gilbert PB
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Sep 26.
1. Falsey AR
2. Branche AR
3. Peasley M
4. Cole M
5. Petrone KK
6. Obrecht S
7. Steinmetz K
8. Smith T
9. Owen A
10. Anderson CS
11. Overby C
12. Peterson DR
13. Walsh EE
Short-Term Immunogenicity of Licensed Subunit RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) Compared to Community-Dwelling Older Adults.; Journal of the American Medical Directors Association. 2024 Sep 21.
1. Henrich TJ
2. Bosch RJ
3. Godfrey C
4. Mar H
5. Nair A
6. Keefer M
7. Fichtenbaum C
8. Moisi D
9. Clagett B
10. Buck AM
11. Deitchman AN
12. Aweeka F
13. Li JZ
14. Kuritzkes DR
15. Lederman MM
16. Hsue PY
17. Deeks SG
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV.; Cell reports. Medicine. 2024 Sep 17.
1. Hahn WO
2. Parks KR
3. Shen M
4. Ozorowski G
5. Janes H
6. Ballweber-Fleming L
7. Woodward Davis AS
8. Duplessis C
9. Tomai M
10. Dey AK
11. Sagawa ZK
12. De Rosa SC
13. Seese A
14. Kallur Siddaramaiah L
15. Stamatatos L
16. Lee WH
17. Sewall LM
18. Karlinsey D
19. Turner HL
20. Rubin V
21. Furth S
22. MacPhee K
23. Duff M
24. Corey L
25. Keefer MC
26. Edupuganti S
27. Frank I
28. Maenza J
29. Baden LR
30. Hyrien O
31. Sanders RW
32. Moore JP
33. Ward AB
34. Tomaras GD
35. Montefiori DC
36. Rouphael N
37. McElrath MJ
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.; The Journal of experimental medicine; Vol 221(10). 2024 Sep 05.